SCHEMBL9683564

SCHEMBL9683564

CC(Cc1ccc(O)cc1)N(CC(O)COc1ccccc1)CC(O)COc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 4/20 0.52
ADRB2 P07550 3/20 0.52
ADRB1 P08588 3/20 0.52
POLB P06746 1/20 0.49
HIF1A Q16665 3/20 0.48
CYP2D6 P10635 2/20 0.48
SLC6A2 P23975 2/20 0.48
MEN1 O00255 1/20 0.48
CYP1A2 P05177 1/20 0.48
HTR1A P08908 1/20 0.48
ADRA2A P08913 1/20 0.48
DRD1 P21728 1/20 0.48
SLC6A4 P31645 1/20 0.48
CYP2C19 P33261 1/20 0.48
ADRA1A P35348 1/20 0.48
OPRM1 P35372 1/20 0.48
DRD3 P35462 1/20 0.48
SLC6A3 Q01959 1/20 0.48
KMT2A Q03164 1/20 0.48
KCNH2 Q12809 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9683556 1.00 ADRB3 (0.52) ADRB3ADRB2ADRB1POLBHIF1A
SCHEMBL10871717 0.86 ADRB2 (0.59) ADRB3ADRB2ADRB1HIF1ACYP2D6
SCHEMBL10871835 0.86 ADRB2 (0.59) ADRB3ADRB2ADRB1HIF1ACYP2D6
SCHEMBL9811973 0.86 ABCB1 (0.56) ADRB3ADRB2ADRB1POLBCYP2D6
SCHEMBL9811990 0.86 ABCB1 (0.56) ADRB3ADRB2ADRB1POLBCYP2D6
SCHEMBL9812047 0.86 ABCB1 (0.53) ADRB3ADRB2ADRB1POLBCYP2D6
SCHEMBL9812066 0.86 ABCB1 (0.53) ADRB3ADRB2ADRB1POLBCYP2D6
SCHEMBL9812089 0.86 ABCB1 (0.56) ADRB3ADRB2ADRB1POLBCYP2D6
SCHEMBL9683677 0.85 ABCB1 (0.55) POLBABCB1LMNAMAOB
SCHEMBL9683688 0.85 ABCB1 (0.55) POLBABCB1LMNAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166218-A Antilipemic agents or antiglycemic agents HOFFMANN-LA ROCHE INC. (US) 1992-11-24 US disclosed
US-5064863-A Catabolic activity, obesity, diabetes HOFFMANN-LA ROCHE INC. (US) 1991-11-12 US disclosed
EP-0140243-B1 PHENOXYPROPANOL AMINES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1988-11-09 EP disclosed
EP-0140243-A2 Phenoxypropanol amines F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1985-05-08 EP disclosed